ZENO - Zenosense, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
+0.0029 (+1.48%)
At close: 3:53PM EST
Stock chart is not supported by your current browser
Previous Close0.1960
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0000 - 0.0000
52 Week Range
Avg. Volume42,975
Market Cap6.179M
Beta (3Y Monthly)6.91
PE Ratio (TTM)N/A
EPS (TTM)-0.0180
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zacks Small Cap Research6 months ago

    Zenosense’s MIDS Cardiac Could Revolutionize Cardiac Troponin Testing

    OTC:ZENO Zenosense, Inc. (OTC:ZENO) is a healthcare technology company located in Valencia, Spain.  The company’s main focus is a novel hand-held point-of-care (POC) cardiac diagnostic device called MIDS ...

  • Newsfile7 months ago

    NetworkNewsAudio Announces Audio Press Release (APR) on Zenosense Demonstrating Impressive Results with MIDS Cardiac

    New York, New York--(Newsfile Corp. - June 28, 2018) - NetworkNewsAudio announces the Audio Press Release (APR) titled "Diagnostics Play Critical Role in Medical Sector," featuring Zenosense (OTC Pink: ZENO). To hear the NetworkNewsAudio version, visit http://nnw.fm/kqyU7To read the original editorial, visit http://nnw.fm/8ZAlrDeveloped by the Company's MIDS Medical Limited joint venture (MML) based at the prestigious Sci-Tech Daresbury campus in the United Kingdom, MIDS Cardiac is a handheld POC technology for the detection of ...

  • We're sorry this is all we were able to find about this topic.